1,6-bis(cyclohexyloximinocarbonyl)hexane has been researched along with glyceryl 2-arachidonate in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Bisogno, T; De Petrocellis, L; Di Marzo, V; Melck, D | 1 |
Campbell, WB; Endsley, MP; Falck, JR; Hillard, CJ; Isbell, MA; Iwamoto, Y; Nithipatikom, K | 1 |
Alava, MA; Anel, A; Barrio, G; Iturralde, M; Lacasa, E; Naval, J; Pardo, J; Piñeiro, A | 1 |
Shimizu, T; Yokotani, K | 1 |
Blankman, JL; Cravatt, BF; Hoover, HS; Niessen, S | 1 |
Cui, Y; Georges, F; Grandes, P; Lafourcade, M; Lassalle, O; Manzoni, OJ; Puente, N; Venance, L | 1 |
Gregg, LC; Hohmann, AG; Jung, KM; Katona, I; Mackie, K; Nyilas, R; Piomelli, D; Spradley, JM; Suplita, RL; Watanabe, M; Zimmer, A | 1 |
Condés-Lara, M; González-Hernández, A; Martínez-Lorenzana, G; Salinas-Abarca, AB | 1 |
8 other study(ies) available for 1,6-bis(cyclohexyloximinocarbonyl)hexane and glyceryl 2-arachidonate
Article | Year |
---|---|
Phosphatidic acid as the biosynthetic precursor of the endocannabinoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin.
Topics: Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Cyclohexanones; Diglycerides; Endocannabinoids; Enzyme Inhibitors; Glycerides; Hydrolysis; Ionomycin; Ionophores; Lipoprotein Lipase; Mice; Neuroblastoma; Phosphatidic Acids; Phospholipase D; Phosphoric Monoester Hydrolases; Prodrugs; Protease Inhibitors; Tumor Cells, Cultured; Type C Phospholipases | 1999 |
2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion.
Topics: Androgens; Arachidonic Acids; Cell Line, Tumor; Cyclic AMP-Dependent Protein Kinases; Cyclohexanones; Endocannabinoids; Glycerides; Humans; Hydrolysis; Lipoprotein Lipase; Male; Neoplasm Invasiveness; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Receptor, Cannabinoid, CB1 | 2004 |
Characterization of the lipolytic pathways that mediate free fatty acid release during Fas/CD95-induced apoptosis.
Topics: Apoptosis; Arachidonic Acids; Bridged-Ring Compounds; Cyclohexanones; Endocannabinoids; Enzyme Inhibitors; fas Receptor; Fatty Acids, Nonesterified; Glycerides; Humans; Jurkat Cells; Ketones; Lipid Metabolism; Lipolysis; Lipoprotein Lipase; Models, Biological; Norbornanes; Palmitic Acid; Phosphatidic Acids; Phosphatidylcholines; Thiocarbamates; Thiones; Type C Phospholipases | 2005 |
Bidirectional roles of the brain 2-arachidonoyl-sn-glycerol in the centrally administered vasopressin-induced adrenomedullary outflow in rats.
Topics: Adrenal Medulla; Animals; Arachidonic Acids; Arginine Vasopressin; Benzoxazines; Brain; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Catecholamines; Cyclohexanones; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; Epinephrine; Glycerides; Indoles; Injections, Intraventricular; Male; Morpholines; Naphthalenes; Norepinephrine; Organophosphonates; Piperidines; Pyrazoles; Rats; Rats, Wistar | 2008 |
Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling.
Topics: Arachidonic Acids; Brain; Cannabinoid Receptor Modulators; Cyclohexanones; Endocannabinoids; Glycerides; Humans; Isoenzymes; Lactones; Lipase; Molecular Structure; Orlistat; Receptor, Cannabinoid, CB1; Serine Proteinase Inhibitors | 2008 |
Polymodal activation of the endocannabinoid system in the extended amygdala.
Topics: Animals; Arachidonic Acids; Biophysics; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Cannabinoid Receptor Modulators; Chromones; Cyclohexanones; Electric Stimulation; Endocannabinoids; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glycerides; In Vitro Techniques; Long-Term Synaptic Depression; Neurons; Nimodipine; Patch-Clamp Techniques; Piperidines; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Septal Nuclei; Signal Transduction; Synapses; Time Factors; TRPV Cation Channels | 2011 |
Activation of type 5 metabotropic glutamate receptors and diacylglycerol lipase-α initiates 2-arachidonoylglycerol formation and endocannabinoid-mediated analgesia.
Topics: Analgesia; Analysis of Variance; Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Cyclohexanones; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Endocannabinoids; Excitatory Amino Acid Antagonists; Glycerides; Lipoprotein Lipase; Male; Methoxyhydroxyphenylglycol; Mice; Microscopy, Immunoelectron; Pain; Periaqueductal Gray; Piperidines; Protease Inhibitors; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Rimonabant; RNA, Messenger; RNA, Small Interfering; Synapses; Tandem Mass Spectrometry | 2012 |
The role of the endocannabinoid 2-arachidonoylglycerol in the in vivo spinal oxytocin-induced antinociception in male rats.
Topics: Aftercare; Analgesics; Animals; Endocannabinoids; Formaldehyde; Humans; Male; Nerve Fibers, Unmyelinated; Oxytocin; Patient Discharge; Rats; Rats, Wistar; Receptors, Oxytocin | 2023 |